Artikel dengan mandat akses publik - Eduardo Rodríguez-ArbolíPelajari lebih lanjut
Tersedia di suatu tempat: 13
FLAMSA-based reduced-intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the …
E Rodríguez-Arbolí, M Labopin, J Tischer, A Brecht, A Ganser, J Finke, ...
Biology of Blood and Marrow Transplantation 26 (11), 2165-2173, 2020
Mandat: Government of Spain
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult …
C Orvain, JA Wilson, M Fang, BM Sandmaier, E Rodríguez-Arbolí, ...
Haematologica 108 (2), 420, 2022
Mandat: US National Institutes of Health
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
C Sargas, R Ayala, MJ Larráyoz, MC Chillón, E Rodriguez-Arboli, ...
Blood Cancer Journal 13 (1), 77, 2023
Mandat: Government of Spain
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell …
E Rodríguez-Arbolí, M Othus, C Orvain, LC Zarling, BM Sandmaier, ...
Haematologica 108 (1), 273, 2022
Mandat: US National Institutes of Health
Long-term outcomes after autologous versus allogeneic stem cell transplantation in molecularly-stratified patients with intermediate cytogenetic risk acute myeloid leukemia: a …
E Rodríguez-Arbolí, D Martínez-Cuadrón, R Rodríguez-Veiga, ...
Transplantation and cellular therapy 27 (4), 311. e1-311. e10, 2021
Mandat: Government of Spain
Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
E Rodriguez-Arboli, C Orvain, M Othus, RB Walter
Bone marrow transplantation 57 (11), 1732-1734, 2022
Mandat: US National Institutes of Health
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or …
RB Walter, BM Sandmaier, M Othus, C Orvain, E Rodríguez-Arbolí, ...
Bone marrow transplantation 58 (4), 377-385, 2023
Mandat: US National Institutes of Health
Association between prior cytotoxic therapy, antecedent hematologic disorder, and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
C Orvain, E Rodríguez-Arbolí, M Othus, BM Sandmaier, HJ Deeg, ...
Cancers 15 (2), 352, 2023
Mandat: US National Institutes of Health
Long-term impact of an educational antimicrobial stewardship program on management of patients with hematological diseases
AB Guisado-Gil, M Aguilar-Guisado, G Peñalva, JA Lepe, I Espigado, ...
Antibiotics 10 (2), 136, 2021
Mandat: Government of Spain
Allocation to matched related or unrelated donor results in similar clinical outcomes without increased risk of failure to proceed to transplant among patients with acute …
E Rodríguez-Arbolí, FJ Márquez-Malaver, N Rodríguez-Torres, ...
Biology of Blood and Marrow Transplantation 25 (1), 183-190, 2019
Mandat: Government of Spain
Phase 1/2 trial of CLAG-M with dose-escalated mitoxantrone in combination with fractionated-dose gemtuzumab ozogamicin for newly diagnosed acute myeloid leukemia and other high …
CD Godwin, E Rodríguez-Arbolí, M Othus, AB Halpern, JS Appelbaum, ...
Cancers 14 (12), 2934, 2022
Mandat: US National Institutes of Health, Alex's Lemonade Stand
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis
E Rodríguez-Arbolí, M Labopin, M Eder, A Brecht, IW Blau, A Huynh, ...
Bone Marrow Transplantation 57 (6), 934-941, 2022
Mandat: Government of Spain
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET® CC-96191
MC Lunn-Halbert, GS Laszlo, S Erraiss, MT Orr, HK Jessup, HJ Thomas, ...
Cancers 16 (5), 877, 2024
Mandat: US National Institutes of Health
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer